Navigation Links
Study Results of Dune Medical's Breast Biopsy System Presented at the Annual Meeting of the Israel Society of Breast Imaging
Date:2/14/2013

BOSTON, Feb. 14, 2013 /PRNewswire/ -- Dune Medical Devices, Inc., announced today that its breakthrough tissue assessment tool for use with currently available vacuum assisted breast biopsy systems was the subject of a presentation to the Israel Society of Breast Imaging at the annual meeting of the society held in Tel Aviv on Wednesday, February 6, 2013.

During his presentation, Dr. Iddo Geltner , Core Technology Director, described the results of Dune's development effort in differentiating tissue types in real time during vacuum assisted breast biopsy procedures using a prototype of their breast biopsy system.  The results, based upon approximately 4,000 histopathologically confirmed samples, demonstrated excellent performance in differentiating 10 breast tissue types in real time.  In addition, use of the prototype device to perform biopsies of ex-vivo specimens demonstrated 92% correlation with final histopathology.

"We believe that our tissue characterization technology, developed initially for use in the recently FDA approved MarginProbe System®, has been successfully adapted for use on commercially available vacuum assisted breast biopsy devices and that this real time information will allow more precise identification of the most suspicious breast tissue.  This technology holds the promise of improved diagnostic accuracy with improved efficiency during the biopsy procedure itself," said Dr. Geltner.

About Early-Stage Breast Cancer Treatment
Breast cancer is the most common type of cancer affecting women in the U.S., with over 285,000 women diagnosed each year.i Over 1.5 million breast biopsies are performed each year to diagnose these women.  Increased breast screening awareness and advancements in imaging technology such as mammograms now catch more breast cancer cases in earlier stages, when the
'/>"/>

SOURCE Dune Medical Devices, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Study Shows Progesterone Shots Do Not Reduce Preterm Delivery in Twin Pregnancies
2. Researchers study bed alarms for nocturnal seizures
3. Grant Awarded to Study Novel Therapies for Muco-Obstructive Diseases Includes Studies on Cempras Solithromycin (CEM-101) in a Cystic Fibrosis Anti-inflammatory Model
4. Avanir Pharmaceuticals Announces Positive Interim Data From Pharmacokinetic Study With Next Generation Compound AVP-786
5. Omeros Announces Toxicology Study Data from MASP-2 Inhibitor
6. Fox News Medical Contributor Explains Study of Side Effects from Prostate-Cancer Treatments
7. Rockwell Medical Announces Iron Delivery Drug SFP Meets Primary Endpoint in PRIME Clinical Study Demonstrating Statistically Significant 37% Reduction in ESA Dose
8. IDEV Announces Results from Revascularization with Supera on Real World Patients (RESTORE) Study, Demonstrating Positive Clinical Outcomes in Significantly Diseased Patients with Long Lesions
9. Vanda Announces Phase IIb/III Clinical Study In Major Depressive Disorder Did Not Meet The Primary Endpoint
10. Targovax AS Announces First Patient Included in Phase I/II Clinical Study With the Therapeutic Cancer Vaccine TG01 in Operable Pancreatic Cancer
11. ADVENTRX Initiates Pivotal Phase 3 Study of ANX-188
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2015)... Hospira, Inc. (NYSE: ... Biosimilar-Behandlungen, sprach heute auf der jährlichen Konferenz der ... London über die Bedeutung ... Biosimilars für Patienten. Das Unternehmen kündigte ... dem Titel „Why extrapolation is paramount to ...
(Date:4/25/2015)... 2015  With the introduction of Elekta,s new Leksell ... are now available for more patients with a wider ... stereotactic radiosurgery system for the brain, integrates advanced motion ... versatility of Gamma Knife radiosurgery. Elekta unveiled Leksell Gamma ... Forum in Barcelona . ...
(Date:4/24/2015)... Hampshire , und BARCELONA ... -- (Stand Nr. 4410) iCAD, Inc. (Nasdaq: ... von moderner Bildanalyse, Lösungen für Behandlungsabläufe und ... Krebserkrankungen, hat heute die sofortige Verfügbarkeit des ... Electronic Brachytherapy (eBx ® ) System ® ...
Breaking Medicine Technology:Führungskräfte von Hospira präsentieren auf bedeutendem europäischen Biosimilars-Forum - Ankündigung eines White Papers über Extrapolation 2Führungskräfte von Hospira präsentieren auf bedeutendem europäischen Biosimilars-Forum - Ankündigung eines White Papers über Extrapolation 3Führungskräfte von Hospira präsentieren auf bedeutendem europäischen Biosimilars-Forum - Ankündigung eines White Papers über Extrapolation 4Führungskräfte von Hospira präsentieren auf bedeutendem europäischen Biosimilars-Forum - Ankündigung eines White Papers über Extrapolation 5Führungskräfte von Hospira präsentieren auf bedeutendem europäischen Biosimilars-Forum - Ankündigung eines White Papers über Extrapolation 6Führungskräfte von Hospira präsentieren auf bedeutendem europäischen Biosimilars-Forum - Ankündigung eines White Papers über Extrapolation 7Führungskräfte von Hospira präsentieren auf bedeutendem europäischen Biosimilars-Forum - Ankündigung eines White Papers über Extrapolation 8New Leksell Gamma Knife to benefit more patients with brain disease 2New Leksell Gamma Knife to benefit more patients with brain disease 3Erste Klinik in Spanien setzt das Xoft Electronic Brachytherapy System für die Behandlung von Brustkrebs im Frühstadium, nicht-melanozytärem Hautkrebs und gynäkologischen Krebserkrankungen ein 2Erste Klinik in Spanien setzt das Xoft Electronic Brachytherapy System für die Behandlung von Brustkrebs im Frühstadium, nicht-melanozytärem Hautkrebs und gynäkologischen Krebserkrankungen ein 3Erste Klinik in Spanien setzt das Xoft Electronic Brachytherapy System für die Behandlung von Brustkrebs im Frühstadium, nicht-melanozytärem Hautkrebs und gynäkologischen Krebserkrankungen ein 4Erste Klinik in Spanien setzt das Xoft Electronic Brachytherapy System für die Behandlung von Brustkrebs im Frühstadium, nicht-melanozytärem Hautkrebs und gynäkologischen Krebserkrankungen ein 5Erste Klinik in Spanien setzt das Xoft Electronic Brachytherapy System für die Behandlung von Brustkrebs im Frühstadium, nicht-melanozytärem Hautkrebs und gynäkologischen Krebserkrankungen ein 6
... CITY, Calif., Jan. 6, 2012  myoscience, Inc. of Redwood ... Robert E. Grant as Chairman of the Board of ... Chief Executive Officer and President of Bausch & Lomb ... Allergan.  Mr. Grant has been a board member for ...
... USHIFU, LLC (US HIFU), a world leader in minimally ... Klein as the company,s new chief executive officer and ... more than 30 years of experience in oncology and ... as president of the radiation oncology division of Roper ...
Cached Medicine Technology:myoscience Announces Robert Grant as Chairman of the Board 2US HIFU Names New Chief Executive Officer 2US HIFU Names New Chief Executive Officer 3
(Date:4/25/2015)... Washington, DC (PRWEB) April 26, 2015 ... for Seniors (ACE.S) , a national endeavor to prepare ... older adults, is a great success, according to a ... of the program's original funding partners. , The ... College of Philadelphia (CCP), under the direction of Elaine ...
(Date:4/25/2015)... 2015 Diversified Communications has announced ... event. The Integrative Healthcare Symposium Canada, as it’s ... at the Sheraton Parkway Toronto North in Ontario. ... of the most anticipated events of the year ... program. The event aims to gather multi-disciplined practitioners ...
(Date:4/25/2015)... 26, 2015 Avid Collector Andrew Hawley ... Rolling Stones Greensboro Coliseum concert posters. The concert was ... the Stone's Second American Tour. , According to ... out of Baltimore, Maryland. This poster blank was used ... southern cites. Globe uses garish lettering and colors on ...
(Date:4/25/2015)... D.C. (PRWEB) April 25, 2015 In ... worldwide will join The Million Nets Pledge, a two-year ... campaign to protect refugee families with one million bednets ... their increased work with UN partners to protect children, ... from malaria. , “There has been a large ...
(Date:4/25/2015)... The Hon. Ellen Tauscher, Independent Chair of the ... following the deadly earthquake in Nepal: , "Today a ... deaths of more than 1,000 people. The aftershocks ... India and other parts of South Asia. I ... of Nepal and the families of the victims. ...
Breaking Medicine News(10 mins):Health News:Hartford Foundation Report Details Success of NLN's Advancing Care Excellence for Seniors (ACE.S) Program 2Health News:Hartford Foundation Report Details Success of NLN's Advancing Care Excellence for Seniors (ACE.S) Program 3Health News:Integrative Healthcare Event launching in Canada 2Health News:Supporters Worldwide Join The Million Nets Pledge on World Malaria Day 2Health News:Supporters Worldwide Join The Million Nets Pledge on World Malaria Day 3Health News:Supporters Worldwide Join The Million Nets Pledge on World Malaria Day 4
... be as effective as a second medication for as ... not been cured by a single antidepressant medication. ... recently published in the Journal of Clinical Psychiatry, found ... can work as well as administering a second antidepressant ...
... , TUESDAY, Aug. 23 (HealthDay News) -- Accidental ... cancer nurses in the United States, a new study ... state who work in outpatient chemotherapy infusion centers and ... eyes had been exposed to the drugs. In ...
... -- Researchers say boys are becoming physically mature earlier ... reaching sexual maturity about 2.5 months earlier every decade ... reason for earlier maturity for boys, as with girls, ... more favorable for it," demographer Joshua Goldstein, director of ...
... By Maureen Salamon HealthDay Reporter , TUESDAY, ... research investigating injectable drugs to treat psoriasis -- an ... the medications are not linked to higher heart risks. ... complete information from drug makers impeded their ability to ...
... than 1 million patients in North America, results from ... as bacteria, in people genetically predisposed to the disorder. ... colon, is one such condition. The aberrant immune ... small signaling proteins secreted by various cells, including ...
... TUESDAY, Aug. 23 (HealthDay News) -- A test that detects ... likely to raise the risk of invasive cervical cancer, when ... many women than the Pap test alone, a new study ... the HPV test alone appears to be enough, said study ...
Cached Medicine News:Health News:Exercise can substitute effectively as second 'medication' for people with depression 2Health News:Nurses at Risk for Accidental Exposure to Chemo Drugs: Study 2Health News:Boys Mature Sexually Earlier Than Ever Before: Study 2Health News:Injectable Psoriasis Drugs May Not Hike Heart Risks: Study 2Health News:Injectable Psoriasis Drugs May Not Hike Heart Risks: Study 3Health News:Novel cytokine protects mice from colitis 2Health News:HPV Test Might Be Better Predictor of Cervical Cancer Than Pap Smear 2Health News:HPV Test Might Be Better Predictor of Cervical Cancer Than Pap Smear 3
... is an innovative, quick and easy ... Use 60% less space on your ... With this amazingly easy-to-use, one-hand system, ... the whole range of Diamond Tips. ...
... Packed conveniently in plastic-wrapped racks of ... to useno need to autoclave. Sterilized Diamond ... efficient sterilization and are delivered with a ... irradiation. Sterilized Diamond Tips are certified free ...
... optimize the accuracy and precision of Finnpipettes. ... widely recognized by customers throughout the world. ... the years and now covers a full ... filter tips, certified pure tips, stepper tips ...
MBP's 200 L large orifice tip is perfect for handling fragile cells, viscous samples and genomic....
Medicine Products: